Effect of Dexmedetomidine and Propofol on Regional Cerebral Tissue Oxygen Saturation
NCT ID: NCT03817112
Last Updated: 2019-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2017-06-15
2019-01-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
.Group I Dexmedetomidine infusion. Group II with Propofol infusion
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect Of Dexmedetomidine On Sublingual Microcirculation In Patients Undergoing On Pump CABG Surgery
NCT02714725
Dexmedetomidine Infusion Effect on Hemodynamic Variables During Craniotomy
NCT04607525
Effect of Topical Airway Block on Hemodynamic Stability Post Induction of Anaesthesia in Cardiac Surgeries
NCT06395727
Dexmedetomidine Sedation and Cardiopulmonary Bypass
NCT02727621
Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation.
NCT06327399
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dexmedetomidine
Infusion of dexmedetomidine
Dexmedetomidine Hydrochloride 0.1 MG/ML
Dexmedetomidine Hydrochloride 0.1 MG/ML infusion at 0.2-0.7 mcg/kg/min
Propofol
Propofol infusion
Propofol 10 MG/ML
Propofol 10 MG/ML infusion at 0.3 -4 mg/kg/h
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine Hydrochloride 0.1 MG/ML
Dexmedetomidine Hydrochloride 0.1 MG/ML infusion at 0.2-0.7 mcg/kg/min
Propofol 10 MG/ML
Propofol 10 MG/ML infusion at 0.3 -4 mg/kg/h
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing on pump coronary artery bypass grafting surgeries
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayman Anis Metry
Clinical professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams Cardiothoracic hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASCSH86/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.